Now showing items 1-20 of 2905

    • Cells Lacking the RB1 Tumor Suppressor Gene are Hyperdependent on Aurora B Kinase for Survival. 

      Oser, MG; Fonseca, R; Chakraborty, AA; Brough, R; Spektor, A; Jennings, RB; Flaifel, A; Novak, JS; Gulati, A; Buss, E; Younger, ST; McBrayer, SK; Cowley, GS; Bonal, DM; Nguyen, Q-D; Brulle-Soumare, L; Taylor, P; Cairo, S; Ryan, CJ; Pease, EJ; Maratea, K; Travers, J; Root, DE; Signoretti, S; Pellman, D; Ashton, S; Lord, CJ; Barry, ST; Kaelin, WG (2018-10-29)
      Small cell lung cancer (SCLC) accounts for 15% of lung cancer and is almost always linked to inactivating RB1 and TP53 mutations. SCLC frequently responds, albeit briefly, to chemotherapy. The canonical function of the RB1 ...
    • Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. 

      Guo, Y; Warren Andersen, S; Shu, X-O; Michailidou, K; Bolla, MK; Wang, Q; Garcia-Closas, M; Milne, RL; Schmidt, MK; Chang-Claude, J; Dunning, A; Bojesen, SE; Ahsan, H; Aittomäki, K; Andrulis, IL; Anton-Culver, H; Arndt, V; Beckmann, MW; Beeghly-Fadiel, A; Benitez, J; Bogdanova, NV; Bonanni, B; Børresen-Dale, A-L; Brand, J; Brauch, H; Brenner, H; Brüning, T; Burwinkel, B; Casey, G; Chenevix-Trench, G; Couch, FJ; Cox, A; Cross, SS; Czene, K; Devilee, P; Dörk, T; Dumont, M; Fasching, PA; Figueroa, J; Flesch-Janys, D; Fletcher, O; Flyger, H; Fostira, F; Gammon, M; Giles, GG; Guénel, P; Haiman, CA; Hamann, U; Hooning, MJ; Hopper, JL; Jakubowska, A; Jasmine, F; Jenkins, M; John, EM; Johnson, N; Jones, ME; Kabisch, M; Kibriya, M; Knight, JA; Koppert, LB; Kosma, V-M; Kristensen, V; Le Marchand, L; Lee, E; Li, J; Lindblom, A; Luben, R; Lubinski, J; Malone, KE; Mannermaa, A; Margolin, S; Marme, F; McLean, C; Meijers-Heijboer, H; Meindl, A; Neuhausen, SL; Nevanlinna, H; Neven, P; Olson, JE; Perez, JIA; Perkins, B; Peterlongo, P; Phillips, K-A; Pylkäs, K; Rudolph, A; Santella, R; Sawyer, EJ; Schmutzler, RK; Seynaeve, C; Shah, M; Shrubsole, MJ; Southey, MC; Swerdlow, AJ; Toland, AE; Tomlinson, I; Torres, D; Truong, T; Ursin, G; Van Der Luijt, RB; Verhoef, S; Whittemore, AS; Winqvist, R; Zhao, H; Zhao, S; Hall, P; Simard, J; Kraft, P; Pharoah, P; Hunter, D; Easton, DF; Zheng, W (2016-08)
      BACKGROUND: Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is ...
    • Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. 

      Schmidt, MK; Hogervorst, F; van Hien, R; Cornelissen, S; Broeks, A; Adank, MA; Meijers, H; Waisfisz, Q; Hollestelle, A; Schutte, M; van den Ouweland, A; Hooning, M; Andrulis, IL; Anton-Culver, H; Antonenkova, NN; Antoniou, AC; Arndt, V; Bermisheva, M; Bogdanova, NV; Bolla, MK; Brauch, H; Brenner, H; Brüning, T; Burwinkel, B; Chang-Claude, J; Chenevix-Trench, G; Couch, FJ; Cox, A; Cross, SS; Czene, K; Dunning, AM; Fasching, PA; Figueroa, J; Fletcher, O; Flyger, H; Galle, E; García-Closas, M; Giles, GG; Haeberle, L; Hall, P; Hillemanns, P; Hopper, JL; Jakubowska, A; John, EM; Jones, M; Khusnutdinova, E; Knight, JA; Kosma, V-M; Kristensen, V; Lee, A; Lindblom, A; Lubinski, J; Mannermaa, A; Margolin, S; Meindl, A; Milne, RL; Muranen, TA; Newcomb, PA; Offit, K; Park-Simon, T-W; Peto, J; Pharoah, PDP; Robson, M; Rudolph, A; Sawyer, EJ; Schmutzler, RK; Seynaeve, C; Soens, J; Southey, MC; Spurdle, AB; Surowy, H; Swerdlow, A; Tollenaar, RAEM; Tomlinson, I; Trentham-Dietz, A; Vachon, C; Wang, Q; Whittemore, AS; Ziogas, A; van der Kolk, L; Nevanlinna, H; Dörk, T; Bojesen, S; Easton, DF (2016-08-10)
      PURPOSE: CHEK2*1100delC is a well-established breast cancer risk variant that is most prevalent in European populations; however, there are limited data on risk of breast cancer by age and tumor subtype, which limits its ...
    • Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer. 

      Painter, JN; O'Mara, TA; Marquart, L; Webb, PM; Attia, J; Medland, SE; Cheng, T; Dennis, J; Holliday, EG; McEvoy, M; Scott, RJ; Ahmed, S; Healey, CS; Shah, M; Gorman, M; Martin, L; Hodgson, SV; Beckmann, MW; Ekici, AB; Fasching, PA; Hein, A; Rübner, M; Czene, K; Darabi, H; Hall, P; Li, J; Dörk, T; Dürst, M; Hillemanns, P; Runnebaum, IB; Amant, F; Annibali, D; Depreeuw, J; Lambrechts, D; Neven, P; Cunningham, JM; Dowdy, SC; Goode, EL; Fridley, BL; Winham, SJ; Njølstad, TS; Salvesen, HB; Trovik, J; Werner, HMJ; Ashton, KA; Otton, G; Proietto, A; Mints, M; Tham, E; Bolla, MK; Michailidou, K; Wang, Q; Tyrer, JP; Hopper, JL; Peto, J; Swerdlow, AJ; Burwinkel, B; Brenner, H; Meindl, A; Brauch, H; Lindblom, A; Chang-Claude, J; Couch, FJ; Giles, GG; Kristensen, VN; Cox, A; Pharoah, PDP; Tomlinson, I; Dunning, AM; Easton, DF; Thompson, DJ; Spurdle, AB; AOCS Group; for RENDOCAS; National Study of Endometrial Cancer Genetics Group (NSECG); Australian National Endometrial Cancer Study Group (ANECS) (2016-11)
      BACKGROUND: The strongest known risk factor for endometrial cancer is obesity. To determine whether SNPs associated with increased body mass index (BMI) or waist-hip ratio (WHR) are associated with endometrial cancer risk, ...
    • Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain 

      Kijewska, M; Viski, C; Turrell, F; Fitzpatrick, A; van Weverwijk, A; Gao, Q; Iravani, M; Isacke, CM (Springer Nature, 2019-12)
    • Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. 

      Yang, Y; Wu, L; Shu, X; Lu, Y; Shu, X-O; Cai, Q; Beeghly-Fadiel, A; Li, B; Ye, F; Berchuck, A; Anton-Culver, H; Banerjee, S; Benitez, J; Bjørge, L; Brenton, JD; Butzow, R; Campbell, IG; Chang-Claude, J; Chen, K; Cook, LS; Cramer, DW; DeFazio, A; Dennis, J; Doherty, JA; Dork, T; Eccles, DM; Velez Edwards, D; Fasching, PA; Fortner, RT; Gayther, SA; Giles, GG; Glasspool, RM; Goode, EL; Goodman, MT; Gronwald, J; Harris, HR; Heitz, F; Hildebrandt, MAT; Høgdall, E; Høgdall, CK; Huntsman, DG; Kar, SP; Karlan, BY; Kelemen, LE; Kiemeney, LA; Kjaer, SK; Koushik, A; Lambrechts, D; Le, ND; Levine, DA; Massuger, LFAG; Matsuo, K; May, T; McNeish, IA; Menon, U; Modugno, F; Monteiro, AN; Moorman, PG; Moysich, KB; Ness, RB; Nevanlinna, H; Olsson, H; Onland-Moret, NC; Park, SK; Paul, J; Pearce, CL; Pejovic, T; Phelan, CM; Pike, MC; Ramus, SJ; Riboli, E; Rodríguez-Antona, C; Romieu, I; Sandler, DP; Schildkraut, JM; Setiawan, VW; Shan, K; Siddiqui, N; Sieh, W; Stampfer, MJ; Sutphen, R; Swerdlow, AJ; Szafron, LM; Teo, SH; Tworoger, SS; Tyrer, JP; Webb, PM; Wentzensen, N; White, E; Willett, WC; Wolk, A; Woo, YL; Wu, AH; Yan, L; Yannoukakos, D; Chenevix-Trench, G; Sellers, TA; Pharoah, PDP; Zheng, W; Long, J (2018-12-17)
      DNA methylation is instrumental for gene regulation. Global changes in the epigenetic landscape have been recognized as a hallmark of cancer. However, the role of DNA methylation in epithelial ovarian cancer (EOC) remains ...
    • Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study. 

      Deltour, I; Schlehofer, B; Massardier-Pilonchéry, A; Schlaefer, K; Armstrong, B; Giles, GG; Siemiatycki, J; Parent, M-E; Krewski, D; McBride, M; Johansen, C; Auvinen, A; Salminen, T; Hours, M; Montestrucq, L; Blettner, M; Berg-Beckhoff, G; Sadetzki, S; Chetrit, A; Lagorio, S; Iavarone, I; Yamaguchi, N; Takebayashi, T; Woodward, A; Cook, A; Tynes, T; Klaeboe, L; Maria Feychting, MF; Lönn, S; Fleming, S; Swerdlow, AJ; Schoemaker, MJ; Moissonnier, M; Kesminiene, A; Cardis, E; Schüz, J; INTERPHONE Study Group (2018-11-05)
      Objective Studies of loud noise exposure and vestibular schwannomas (VS) have shown conflicting results. The population-based INTERPHONE case‒control study was conducted in 13 countries during 2000-2004. In this paper, we ...
    • Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. 

      Rambau, PF; Vierkant, RA; Intermaggio, MP; Kelemen, LE; Goodman, MT; Herpel, E; Pharoah, PD; Kommoss, S; Jimenez-Linan, M; Karlan, BY; Gentry-Maharaj, A; Menon, U; Polo, SH; Candido Dos Reis, FJ; Doherty, JA; Gayther, SA; Sharma, R; Larson, MC; Harnett, PR; Hatfield, E; de Andrade, JM; Nelson, GS; Steed, H; Schildkraut, JM; Carney, ME; Høgdall, E; Whittemore, AS; Widschwendter, M; Kennedy, CJ; Wang, F; Wang, Q; Wang, C; Armasu, SM; Daley, F; Coulson, P; Jones, ME; Anglesio, MS; Chow, C; de Fazio, A; García-Closas, M; Brucker, SY; Cybulski, C; Harris, HR; Hartkopf, AD; Huzarski, T; Jensen, A; Lubiński, J; Oszurek, O; Benitez, J; Mina, F; Staebler, A; Taran, FA; Pasternak, J; Talhouk, A; Rossing, MA; Hendley, J; AOCS Group; Edwards, RP; Fereday, S; Modugno, F; Ness, RB; Sieh, W; El-Bahrawy, MA; Winham, SJ; Lester, J; Kjaer, SK; Gronwald, J; Sinn, P; Fasching, PA; Chang-Claude, J; Moysich, KB; Bowtell, DD; Hernandez, BY; Luk, H; Behrens, S; Shah, M; Jung, A; Ghatage, P; Alsop, J; Alsop, K; García-Donas, J; Thompson, PJ; Swerdlow, AJ; Karpinskyj, C; Cazorla-Jiménez, A; García, MJ; Deen, S; Wilkens, LR; Palacios, J; Berchuck, A; Koziak, JM; Brenton, JD; Cook, LS; Goode, EL; Huntsman, DG; Ramus, SJ; Köbel, M (2018-10)
      We aimed to validate the prognostic association of p16 expression in ovarian high-grade serous carcinomas (HGSC) and to explore it in other ovarian carcinoma histotypes. p16 protein expression was assessed by clinical-grade ...
    • High-frequency ultrasound for diagnosing skin cancer in adults. 

      Dinnes, J; Bamber, J; Chuchu, N; Bayliss, SE; Takwoingi, Y; Davenport, C; Godfrey, K; O'Sullivan, C; Matin, RN; Deeks, JJ; Williams, HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group (2018-12-04)
      BACKGROUND: Early, accurate detection of all skin cancer types is essential to guide appropriate management and to improve morbidity and survival. Melanoma and squamous cell carcinoma (SCC) are high-risk skin cancers with ...
    • Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. 

      Ferrante di Ruffano, L; Takwoingi, Y; Dinnes, J; Chuchu, N; Bayliss, SE; Davenport, C; Matin, RN; Godfrey, K; O'Sullivan, C; Gulati, A; Chan, SA; Durack, A; O'Connell, S; Gardiner, MD; Bamber, J; Deeks, JJ; Williams, HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group (2018-12-04)
      BACKGROUND: Early accurate detection of all skin cancer types is essential to guide appropriate management and to improve morbidity and survival. Melanoma and cutaneous squamous cell carcinoma (cSCC) are high-risk skin ...
    • Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. 

      Williams, CL; Jones, ME; Swerdlow, AJ; Botting, BJ; Davies, MC; Jacobs, I; Bunch, KJ; Murphy, MFG; Sutcliffe, AG (2018-07-11)
      OBJECTIVE: To investigate the risks of ovarian, breast, and corpus uteri cancer in women who have had assisted reproduction. DESIGN: Large, population based, data linkage cohort study. SETTING AND PARTICIPANTS: All women ...
    • Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial. 

      Hurvitz, SA; Quek, RGW; Turner, NC; Telli, ML; Rugo, HS; Mailliez, A; Ettl, J; Grischke, E; Mina, LA; Balmaña, J; Fasching, PA; Bhattacharyya, H; Hannah, AL; Robson, ME; Wardley, AM (2018-11)
      BACKGROUND: Talazoparib (1 mg/day) exhibited promising efficacy and safety in patients with advanced breast cancer during ABRAZO (NCT02034916); this study evaluated patient-reported outcomes (PROs). PATIENTS AND METHODS: ...
    • PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. 

      Jiao, X; Aravidis, C; Marikkannu, R; Rantala, J; Picelli, S; Adamovic, T; Liu, T; Maguire, P; Kremeyer, B; Luo, L; von Holst, S; Kontham, V; Thutkawkorapin, J; Margolin, S; Du, Q; Lundin, J; Michailidou, K; Bolla, MK; Wang, Q; Dennis, J; Lush, M; Ambrosone, CB; Andrulis, IL; Anton-Culver, H; Antonenkova, NN; Arndt, V; Beckmann, MW; Blomqvist, C; Blot, W; Boeckx, B; Bojesen, SE; Bonanni, B; Brand, JS; Brauch, H; Brenner, H; Broeks, A; Brüning, T; Burwinkel, B; Cai, Q; Chang-Claude, J; NBCS Collaborators; Couch, FJ; Cox, A; Cross, SS; Deming-Halverson, SL; Devilee, P; Dos-Santos-Silva, I; Dörk, T; Eriksson, M; Fasching, PA; Figueroa, J; Flesch-Janys, D; Flyger, H; Gabrielson, M; García-Closas, M; Giles, GG; González-Neira, A; Guénel, P; Guo, Q; Gündert, M; Haiman, CA; Hallberg, E; Hamann, U; Harrington, P; Hooning, MJ; Hopper, JL; Huang, G; Jakubowska, A; Jones, ME; Kerin, MJ; Kosma, V-M; Kristensen, VN; Lambrechts, D; Le Marchand, L; Lubinski, J; Mannermaa, A; Martens, JWM; Meindl, A; Milne, RL; Mulligan, AM; Neuhausen, SL; Nevanlinna, H; Peto, J; Pylkäs, K; Radice, P; Rhenius, V; Sawyer, EJ; Schmidt, MK; Schmutzler, RK; Seynaeve, C; Shah, M; Simard, J; Southey, MC; Swerdlow, AJ; Truong, T; Wendt, C; Winqvist, R; Zheng, W; kConFab/AOCS Investigators; Benitez, J; Dunning, AM; Pharoah, PDP; Easton, DF; Czene, K; Hall, P; Lindblom, A (2017-11-28)
      Most non-BRCA1/2 breast cancer families have no identified genetic cause. We used linkage and haplotype analyses in familial and sporadic breast cancer cases to identify a susceptibility locus on chromosome 6q. Two independent ...
    • Does age matter? A comparison of health-related quality of life issues of adolescents and young adults with cancer. 

      Sodergren, SC; Husson, O; Rohde, GE; Tomasewska, IM; Griffiths, H; Pessing, A; Yarom, N; Hooker, L; Din, A; Darlington, AS; EORTC Quality of Life Group (2018-11)
      OBJECTIVE: Health-related quality of life (HRQoL) concerns of adolescents and young adults (AYAs) aged 14-25 years were compared with those of older adults (26-60 years) with cancer. METHODS: AYAs and older adults receiving ...
    • A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 

      Wu, L; Shi, W; Long, J; Guo, X; Michailidou, K; Beesley, J; Bolla, MK; Shu, X-O; Lu, Y; Cai, Q; Al-Ejeh, F; Rozali, E; Wang, Q; Dennis, J; Li, B; Zeng, C; Feng, H; Gusev, A; Barfield, RT; Andrulis, IL; Anton-Culver, H; Arndt, V; Aronson, KJ; Auer, PL; Barrdahl, M; Baynes, C; Beckmann, MW; Benitez, J; Bermisheva, M; Blomqvist, C; Bogdanova, NV; Bojesen, SE; Brauch, H; Brenner, H; Brinton, L; Broberg, P; Brucker, SY; Burwinkel, B; Caldés, T; Canzian, F; Carter, BD; Castelao, JE; Chang-Claude, J; Chen, X; Cheng, T-YD; Christiansen, H; Clarke, CL; NBCS Collaborators; Collée, M; Cornelissen, S; Couch, FJ; Cox, D; Cox, A; Cross, SS; Cunningham, JM; Czene, K; Daly, MB; Devilee, P; Doheny, KF; Dörk, T; Dos-Santos-Silva, I; Dumont, M; Dwek, M; Eccles, DM; Eilber, U; Eliassen, AH; Engel, C; Eriksson, M; Fachal, L; Fasching, PA; Figueroa, J; Flesch-Janys, D; Fletcher, O; Flyger, H; Fritschi, L; Gabrielson, M; Gago-Dominguez, M; Gapstur, SM; García-Closas, M; Gaudet, MM; Ghoussaini, M; Giles, GG; Goldberg, MS; Goldgar, DE; González-Neira, A; Guénel, P; Hahnen, E; Haiman, CA; Håkansson, N; Hall, P; Hallberg, E; Hamann, U; Harrington, P; Hein, A; Hicks, B; Hillemanns, P; Hollestelle, A; Hoover, RN; Hopper, JL; Huang, G; Humphreys, K; Hunter, DJ; Jakubowska, A; Janni, W; John, EM; Johnson, N; Jones, K; Jones, ME; Jung, A; Kaaks, R; Kerin, MJ; Khusnutdinova, E; Kosma, V-M; Kristensen, VN; Lambrechts, D; Le Marchand, L; Li, J; Lindström, S; Lissowska, J; Lo, W-Y; Loibl, S; Lubinski, J; Luccarini, C; Lux, MP; MacInnis, RJ; Maishman, T; Kostovska, IM; Mannermaa, A; Manson, JE; Margolin, S; Mavroudis, D; Meijers-Heijboer, H; Meindl, A; Menon, U; Meyer, J; Mulligan, AM; Neuhausen, SL; Nevanlinna, H; Neven, P; Nielsen, SF; Nordestgaard, BG; Olopade, OI; Olson, JE; Olsson, H; Peterlongo, P; Peto, J; Plaseska-Karanfilska, D; Prentice, R; Presneau, N; Pylkäs, K; Rack, B; Radice, P; Rahman, N; Rennert, G; Rennert, HS; Rhenius, V; Romero, A; Romm, J; Rudolph, A; Saloustros, E; Sandler, DP; Sawyer, EJ; Schmidt, MK; Schmutzler, RK; Schneeweiss, A; Scott, RJ; Scott, CG; Seal, S; Shah, M; Shrubsole, MJ; Smeets, A; Southey, MC; Spinelli, JJ; Stone, J; Surowy, H; Swerdlow, AJ; Tamimi, RM; Tapper, W; Taylor, JA; Terry, MB; Tessier, DC; Thomas, A; Thöne, K; Tollenaar, RAEM; Torres, D; Truong, T; Untch, M; Vachon, C; Van Den Berg, D; Vincent, D; Waisfisz, Q; Weinberg, CR; Wendt, C; Whittemore, AS; Wildiers, H; Willett, WC; Winqvist, R; Wolk, A; Xia, L; Yang, XR; Ziogas, A; Ziv, E; kConFab/AOCS Investigators; Dunning, AM; Pharoah, PDP; Simard, J; Milne, RL; Edwards, SL; Kraft, P; Easton, DF; Chenevix-Trench, G; Zheng, W (2018-07)
      The breast cancer risk variants identified in genome-wide association studies explain only a small fraction of the familial relative risk, and the genes responsible for these associations remain largely unknown. To identify ...
    • Towards personalized treatment in multiple myeloma based on molecular characteristics. 

      Pawlyn, C; Davies, FE (2018-12-26)
      To date, the choice of therapy for an individual multiple myeloma patient has been based on clinical factors such as age and co-morbidities. The widespread evolution, validation and clinical utilization of molecular ...
    • A Life Put on Pause: An Exploration of the Health-Related Quality of Life Issues Relevant to Adolescents and Young Adults with Cancer. 

      Sodergren, SC; Husson, O; Rohde, GE; Tomasewska, IM; Vivat, B; Yarom, N; Griffiths, H; Darlington, A-S (2018-08)
      PURPOSE: In recent years, the assessment of health-related quality of life (HRQoL) has been recognized as particularly informative to healthcare providers. For adolescents and young adults (AYAs), the impact of a cancer ...
    • Health-related quality of life among cancer patients in their last year of life: results from the PROFILES registry. 

      Raijmakers, NJH; Zijlstra, M; van Roij, J; Husson, O; Oerlemans, S; van de Poll-Franse, LV (2018-10)
      PURPOSE: The aim of this study was to assess health-related quality of life (HRQoL) in the last year of life of cancer patients stratified by four periods of time before death. PATIENTS AND METHODS: Between 2008 and 2015, ...
    • Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C. 

      Cornish, AJ; Hoang, PH; Dobbins, SE; Law, PJ; Chubb, D; Orlando, G; Houlston, RS (2019-01-08)
      The identification of driver mutations is fundamental to understanding oncogenesis. Although genes frequently mutated in B-cell lymphoma have been identified, the search for driver mutations has largely focused on the ...
    • Diagnostic ultrasound probes: a typology and overview of technologies 

      De Luca, R; Dattoma, T; Forzoni, L; Bamber, J; Palchetti, P; Gubbini, A (Walter de Gruyter GmbH, 2018-09-01)
      <jats:title>Abstract</jats:title> <jats:p>The routine clinical use of diagnostic ultrasound (US) has spread considerably worldwide in recent decades. This is due in large part to the availability of US probes that enable ...